Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature

• Publication date

  2014-06-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature13489PMID 24990750PMCID PMC4809146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarker Discovery by Sparse Canonical Correlation Analysis of Complex Clinical Phenotypes of Tuberculosis and Malaria

  2013cited by this paper
• Inflammation in tuberculosis: interactions, imbalances and interventions.

  2013cited by this paper
• Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease

  2013cited by this paper
• Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway

  2013cited by this paper
• The immune response in tuberculosis.

  2013cited by this paper
• Bettering BCG: a tough task for a TB vaccine?

  2013cited by this paper
• Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.

  2012cited by this paper
• Genome-Wide Expression Profiling Identifies Type 1 Interferon Response Pathways in Active Tuberculosis

  2012cited by this paper
• Fresh Approaches to Anti-Infective Therapies

  2012cited by this paper
• Tuberculosis

  2011cited by this paper
• Human gene expression profiles of susceptibility and resistance in tuberculosis

  2011cited by this paper
• Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.

  2011cited by this paper
• Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

  2010cited by this paper
• Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

  2010cited by this paper
• The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans.

  2010cited by this paper
• Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections

  2010cited by this paper
• Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo

  2010cited by this paper
• An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis

  2010cited by this paper
• Tuberculosis: What We Don’t Know Can, and Does, Hurt Us

  2010cited by this paper
• The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

  2009cited by this paper
• Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair

  2009cited by this paper
• Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

  2008cited by this paper
• Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death

  2008cited by this paper
• The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1

  2007cited by this paper
• Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.

  2005cited by this paper
• Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β

  2001cited by this paper
• Nitric oxide modulates interleukin-1beta and tumour necrosis factor-alpha synthesis, and disease regression by alveolar macrophages in pulmonary tuberculosis.

  2001cited by this paper
• Nitric Oxide Modulates Interleukin-1 β and Tumor Necrosis Factor- α Synthesis by Alveolar Macrophages in Pulmonary Tuberculosis

  2000cited by this paper
• Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis.

  2000cited by this paper
• Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis.

  1999cited by this paper
• Increased TNF-α, IL-1β and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis

  1999cited by this paper
• Compensatory Prostaglandin E2 Biosynthesis in Cyclooxygenase 1 or 2 Null Cells

  1998cited by this paper
• Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis.

  1996cited by this paper
• Animal Tissue Techniques

  1974cited by this paper

• Strongyloides stercoralis coinfection impairs immune control of Mycobacterium tuberculosis in TB infected individuals

  2026cites this paper
• Alveolar macrophages shape tuberculosis susceptibility by delaying protective immunity.

  2026cites this paper
• Sepsis induces long-term reprogramming of human HSPCs and drives myeloid dysregulation in sepsis survivors

  2026cites this paper
• Strong sustained type I IFN signaling acts cell intrinsically to impair IFNγ responses and cause tuberculosis susceptibility

  2026cites this paper
• Functional analysis of distinct factors linked to the development of latent to active tuberculosis

  2026cites this paper
• EsxN drives ISG15-mediated dsDNA release to activate cGAS-STING signaling and promote mycobacterial survival

  2026cites this paper
• Pharmacological inhibition of USP18 improves antibacterial responses and the intracellular control of Mycobacterium tuberculosis in macrophages

  2026cites this paper
• The Dynamics of Human Cytomegalovirus Markers in Tuberculosis Disease Among People With Human Immunodeficiency Virus on Long-term Antiretroviral Therapy: A Nested Case-Control Study

  2026cites this paper
• Type I interferons in bacterial diseases: myeloid cells at the crossroads of protection and pathology

  2026cites this paper
• Shared and distinct responses of human and murine alveolar macrophages and monocyte-derived macrophages to Mycobacterium tuberculosis

  2025cites this paper
• Innate biosignature of treatment failure in human cutaneous leishmaniasis

  2025cites this paper
• Effects of Modified Xuanbai Chengqi Decoction Against Secondary Streptococcus pneumoniae Infection Following Influenza Virus Infection: A Multi-Omics Analysis.

  2025cites this paper
• High-dose intravenous BCG vaccination induces enhanced immune signaling in the airways

  2025cites this paper
• Interferons in health and disease.

  2025cites this paper
• The Role of Inflammation in the Pathogenesis of Comorbidity of Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis

  2025cites this paper
• Comparison the impact of IFN-β alone or in combination with vitamin D on critical pathways involved in AML progression

  2025cites this paper
• Lipid deprivation amplifies type I IFN responses in monocytes through prenylation: insights from familial combined hypolipidemia type 2

  2025cites this paper
• Mycobacterium tuberculosis manipulates LINC02528 in macrophages to modulate anti-tuberculosis metabolic immunity

  2025cites this paper
• Genetic Insights Into Depression Induced by Tuberculosis via Mediating Roles of Interleukins: Evidence From Mendelian Randomization

  2025cites this paper
• Evolution of Mycobacterium tuberculosis transcription regulation is associated with increased transmission and drug resistance

  2025cites this paper
• Shared and distinct responses of human and murine alveolar macrophages and monocyte-derived macrophages to Mycobacterium tuberculosis

  2025cites this paper
• B cells inhibit IL-1 family cytokine production and Mycobacterium tuberculosis growth in human CD14+ cells

  2025cites this paper
• SP140 limits type I interferon–driven pathology, preserving T cell motility and promoting resistance in tuberculosis

  2025cites this paper
• Drugs Used in the Treatment of Viral Infections for the Prevention of Airway Remodeling in Asthma

  2025cites this paper
• Host-Directed Therapeutic for the treatment of Mycobacterium tuberculosis.

  2025cites this paper
• Host-directed therapy for tuberculosis

  2025cites this paper
• Unlocking Immunity Within: Inflammatory Monocytes Stimulate T Cells at Immune Hubs in the Tumor Microenvironment.

  2025cites this paper
• Systematic review of innate immune responses against Mycobacterium tuberculosis complex infection in animal models

  2025cites this paper
• From Cytokines to Tuberculosis and Back: My Journey to Understanding the Immune Response to Infection.

  2025cites this paper
• The Role of Type I Interferons in Tuberculosis and in Tuberculosis-Risk-Associated Comorbidities

  2025cites this paper
• VPS18 contributes to phagosome membrane integrity in Mycobacterium tuberculosis–infected macrophages

  2025cites this paper
• For Better or Worse: Type I Interferon Responses in Bacterial Infection

  2025cites this paper
• Host-Directed Insights into Mycobacterial Infections: Toward Targeted Immunomodulation.

  2025cites this paper
• Protein kinase F regulates the virulence of Mycobacterium tuberculosis

  2025cites this paper
• Deconvoluting the interplay of innate and adaptive immunity in BCG-induced nonspecific and TB-specific host resistance.

  2025cites this paper
• Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes

  2025cites this paper
• ATG5 suppresses type I IFN-dependent neutrophil effector functions during Mycobacterium tuberculosis infection in mice

  2025cites this paper
• Lessons from cross-pathogen studies: understanding the metabolic rewiring of macrophages upon infection

  2025cites this paper
• Mycobacterial ESAT-6 triggers cGAS-STING pathway via the GSDMD-NT dependent mitochondria dysfunction

  2025cites this paper
• Working in negative space: Type I interferon mediated immuno-modulation through transcriptional suppression in disease and homeostasis

  2025cites this paper
• Taurine transport is a critical modulator of ionic fluxes during NLRP3 inflammasome activation.

  2025cites this paper
• Nucleotide‐Binding Oligomerization Domain 2 in Signaling, Immunity, and Mycobacterial Infection

  2025cites this paper
• Immunological Interventions in Bacterial Infections: From Mechanisms to Clinical Applications

  2025cites this paper
• Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosis

  2025cites this paper
• NINJ1 is activated by Mycobacterium tuberculosis ESX-1 secreted effector EsxA and mediates necrosis of infected human macrophages

  2025cites this paper
• Targeting ALOX5/LTA4H driven granuloma caseation as a host-directed strategy for control of TB associated lung damage

  2025cites this paper
• Single-cell analysis reveals Mycobacterium tuberculosis ESX-1–mediated accumulation of permissive macrophages in infected mouse lungs

  2025cites this paper
• A Mycobacterium tuberculosis multi-epitope DNA vaccine encoding adaptive immune antigens provokes IFNγ/Th1 immunity and confers potential protection.

  2025cites this paper
• Exposure to polyhexamethylene guanidine, a humidifier disinfectant, disrupts protective immunity and accelerates tuberculosis progression via type I IFN signaling and neutrophil influx in mice.

  2025cites this paper
• BCG and beyond: unlocking new frontiers in TB vaccine development

  2025cites this paper
• Advancing roles of nitric oxide in tuberculosis: Promising targets for novel anti-TB therapeutics.

  2025cites this paper
• The dual role of type I interferons in bacterial infections: from immune defense to pathogenesis

  2025cites this paper
• Evolution of Mycobacterium tuberculosis transcription regulation is associated with increased transmission and drug resistance

  2025cites this paper
• Immunoregulatory macrophages induced by mycobacterial nonpolar lipids.

  2025cites this paper
• Mycobacterium bovis frd operon phase variation hijacks succinate signaling to drive immunometabolic rewiring and pathogenicity

  2025cites this paper
• How macrophage heterogeneity affects tuberculosis disease and therapy

  2025cites this paper
• Type I IFN drives neutrophil swarming, impeding lung T cell–macrophage interactions and TB control

  2025cites this paper
• Paired analysis of host and pathogen genomes identifies determinants of human tuberculosis

  2024influential citation
• Pathogenic role for CD101-negative neutrophils in the type I interferon-mediated immunopathogenesis of tuberculosis

  2024cites this paper
• The cGAS-STING pathway in HIV-1 and Mycobacterium tuberculosis coinfection

  2024cites this paper
• Host Immune Pathways to Mycobacterium tuberculosis Infection

  2024cites this paper
• Tuberculosis as an unconventional interferonopathy.

  2024cites this paper
• The inflammasome-activating poxvirus peptide IAMP29 promotes antimicrobial and anticancer responses

  2024cites this paper
• Intersecting epidemics: deciphering the complexities of tuberculosis-diabetes comorbidity

  2024cites this paper
• Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus

  2024cites this paper
• Recent advances in understanding the human host immune response in tuberculous meningitis

  2024cites this paper
• Mechanisms of immune evasion by Mycobacterium tuberculosis: the impact of T7SS and cell wall lipids on host defenses

  2024cites this paper
• Progranulin protects against Clostridioides difficile infection by enhancing IL-22 production

  2024cites this paper
• The Integration of Omics: A Promising Approach to Personalized Tuberculosis Treatment

  2024cites this paper
• Differential requirement of formyl peptide receptor 1 in macrophages and neutrophils in the host defense against Mycobacterium tuberculosis Infection

  2024cites this paper
• Unmasking the hidden impact of viruses on tuberculosis risk

  2024cites this paper
• Permissive lung neutrophils facilitate tuberculosis immunopathogenesis in male phagocyte NADPH oxidase-deficient mice

  2024cites this paper
• TGFβ primes alveolar-like macrophages to induce type I IFN following TLR2 activation

  2024cites this paper
• A multistage protein subunit vaccine as BCG-booster confers protection against Mycobacterium tuberculosis infection in murine models.

  2024cites this paper
• Immunological roads diverged: mapping tuberculosis outcomes in mice.

  2024cites this paper
• Cytosolic serpins act in a cytoprotective feedback loop that limits ESX-1-dependent death of Mycobacterium marinum-infected macrophages

  2024cites this paper
• The role of inflammasomes as central inflammatory hubs in Mycobacterium tuberculosis infection

  2024cites this paper
• Type I interferon responses contribute to immune protection against mycobacterial infection

  2024cites this paper
• Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing

  2024cites this paper
• Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis

  2024cites this paper
• Advances in understanding immune homeostasis in latent tuberculosis infection.

  2024cites this paper
• Mycobacterium tuberculosis infection induces a novel type of cell death: Ferroptosis.

  2024cites this paper
• Natural products in anti-tuberculosis host-directed therapy.

  2024cites this paper
• Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections

  2024influential citation
• The impact of Mycobacterium tuberculosis on the macrophage cholesterol metabolism pathway

  2024cites this paper
• Mental illness and pulmonary tuberculosis: a bidirectional two-sample Mendelian randomization study

  2024cites this paper
• Innate biosignature of treatment failure in human cutaneous leishmaniasis

  2024cites this paper
• Mycobacterial CpsA activates type I IFN signaling in macrophages via cGAS-mediated pathway

  2024cites this paper
• Type I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death

  2024cites this paper
• A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection

  2024cites this paper
• Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics.

  2024cites this paper
• Effectiveness of Surgical Treatment of Patients with Destructive Pulmonary Tuberculosis (Meta-Analysis)

  2024cites this paper
• Improved cure rate of periprosthetic joint infection through targeted antibiotic therapy based on integrated pathogen diagnosis strategy

  2024cites this paper
• The balance between antiviral and antibacterial responses during M. tuberculosis infection is regulated by the ubiquitin ligase CBL

  2024cites this paper
• Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS-CoV-2

  2024cites this paper
• Role of EP4 factor in paediatric type 1 diabetes mellitus: a comprehensive review focusing on the honeymoon period

  2024cites this paper
• A complex immune communication between eicosanoids and pulmonary macrophages.

  2024cites this paper
• The role of ESAT-6 in tuberculosis immunopathology

  2024influential citation
• A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y

  2024cites this paper
• Associations between type 1 diabetes and pulmonary tuberculosis: a bidirectional mendelian randomization study

  2024cites this paper